Yan Ye, Chen Yi-Na, Zhao Qian, Chen Chao, Lin Chun-Jing, Jin Yin, Pan Shuang, Wu Jian-Sheng
Ye Yan, Yi-Na Chen, Qian Zhao, Chao Chen, Yin Jin, Shuang Pan, Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
World J Gastroenterol. 2017 Feb 28;23(8):1443-1449. doi: 10.3748/wjg.v23.i8.1443.
To explore the association between () infection status, intestinal metaplasia (IM), and colorectal adenomas.
We retrospectively reviewed 1641 individuals aged ≥ 40 years who underwent physical examination, laboratory testing, C-urea breath testing, gastroscopy, colonoscopy, and an interview to ascertain baseline characteristics and general state of health. Histopathological results were obtained by gastric and colorectal biopsies.
The prevalence of infection and adenomas was 51.5% (845/1641) and 18.1% (297/1641), respectively. infection was significantly correlated with an increased risk of colorectal adenomas (crude OR = 1.535, 95%CI: 1.044-1.753, = 0.022; adjusted OR = 1.359, 95%CI: 1.035-1.785, = 0.028). Individuals with IM had an elevated risk of colorectal adenomas (crude OR = 1.664, 95%CI: 1.216-2.277, = 0.001; adjusted OR = 1.381, 95%CI: 0.998-1.929, = 0.059). Stratification based on infection stage and IM revealed that IM accompanied by infection was significantly associated with an increased risk of adenomas (crude OR = 2.109, 95%CI: 1.383-3.216, = 0.001; adjusted OR = 1.765, 95%CI: 1.130-2.757, = 0.012).
-related IM is associated with a high risk of colorectal adenomas in Chinese individuals.
探讨()感染状况、肠化生(IM)与结直肠腺瘤之间的关联。
我们回顾性分析了1641名年龄≥40岁接受体检、实验室检测、C尿素呼气试验、胃镜检查、结肠镜检查及访谈以确定基线特征和总体健康状况的个体。通过胃和结直肠活检获得组织病理学结果。
()感染和腺瘤的患病率分别为51.5%(845/1641)和18.1%(297/1641)。()感染与结直肠腺瘤风险增加显著相关(粗优势比=1.535,95%置信区间:1.044 - 1.753,P = 0.022;调整后优势比=1.359,95%置信区间:1.035 - 1.785,P = 0.028)。患有IM的个体患结直肠腺瘤的风险升高(粗优势比=1.664,95%置信区间:1.216 - 2.277,P = 0.001;调整后优势比=1.381,95%置信区间:0.998 - 1.929,P = 0.059)。基于()感染阶段和IM进行分层显示,伴有()感染的IM与腺瘤风险增加显著相关(粗优势比=2.109,95%置信区间:1.383 - 3.216,P = 0.001;调整后优势比=1.765,95%置信区间:1.130 - 2.757,P = 0.012)。
在中国个体中,与()相关的IM与结直肠腺瘤的高风险相关。